Brief: Vaccinex Reports Publication Of Results From Trial In Non-Small Cell Lung Cancer In Peer-Reviewed Journal
21/04/2021 13:03
April 21 (Reuters) - Vaccinex Inc VCNX.O :
* VACCINEX ANNOUNCES PUBLICATION OF RESULTS FROM
CLASSICAL-LUNG
PHASE 1B/2 CLINICAL TRIAL IN NON-SMALL CELL LUNG CANCER IN THE
PEER-REVIEWED JOURNAL CLINICAL CANCER RESEARCH
Source text for Eikon: ID:nGNX303n1F
Further company coverage: VCNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease